Lina Quteineh

Awards :

Best Young Researcher Thesis Work in Clinical Pharmacology.Clermont-Ferrand,France. the 1st price of SFPT 2008

Publications :

  1. Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose. Quteineh L., Verstuyft C., Descot C., Dubert L., Robert A., Jaillon P., Becquemont L. Thromb. Haemost. 2005 ; 94 (3) : 690-1. (IF 2008= 3.8).
  2. Impact of VKORC1 haplotypes on the long-term graft survival in kidney transplantation. L. Quteineh, C. Verstuyft, A. Durrbach, A. Letierce , B. Charpentier , L. Becquemont. Transplantation. 2008 Sep 27; 86(6):779-83. (IF 2008= 3.82).
  3. Influence of CYP3A5 genetic polymorphism on tacrolimus daily requirements, acute rejection and nephrotoxicity in renal graft recipients. Quteineh L., Verstuyft C., Furlan V., Durrbach A., Letierce A., Taburet AM., Charpentier B., Becquemont L. Basic Clin Pharmacol Toxicol. 2008 Dec; 103(6):546-52. (IF 2009= 2.31).
  4. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; the French Registry of Acute ST-Elevation and Non–ST-Elevation Myocardial Infarction (FAST-MI) Investigators. N Engl J Med. 2009 Jan 22; 360(4):363-375. Epub 2008 Dec 22. (IF 2008= 50.0).
  5. Pharmacogenetics in immunosuppressants: impact on dose requirement of calcineurin inhibitors in renal and liver pediatric transplant recipients. Quteineh L., Verstuyft C. Curr Opin Organ Transplant. 2010 Oct; 15(5):601-7 (IF 2009 = 0.43).
  6. OATP1B1 genetic polymorphism influences Mycophenolic acid tolerance in renal transplant recipients. Michelon H., König J., Durrbach A., Quteineh L., Verstuyft C., Furlan V., Ferlicot S., Letierce A., Charpentier B., Fromm M.F.and Becquemont L. Pharmacogenomics. 2010 Dec; 11(12):1703-13. (IF 2009 = 3.55).
  7. Influence of CRTC1 polymorphisms on body mass index and fat mass in patients with psychotropic treatments and in the general adult population. E. Choong, L. Quteineh, JR Cardinaux, M. Gholam-Rezaee, F. Vandenberghe, M. Dobrinas, G. Bondolfi, M. Etter, L. Holzer, P. Magistretti, A. von Gunten, M. Preisig, P. Vollenweider, the ODEX team, JS. Beckmann, FP. Pralong, G. Waeber, Zoltan Kutalik, P. Conus, M. Bochud, CB. Eap. (In Press, JAMA Psychiatry) (IF 2011 = 12.06)


end faq


An Amazing Experience

I was among the 3rd batch of Al-Quds medical school graduates and right after my graduation I got a scholarship through Al-Quds University to do a PhD in pharmacology in Paris/France which was a very good and enriching experience. I’ll be always thankful to the medical school deanship and Al-Quds University administration for this opportunity.

As I mentioned above, I was among the first batches of medical school graduates; I spent 7 years in Al-Quds University as a student…it was not easy… the pressure… the expectations…but at the same time it made us strong and solid. I remember how people around us doubted the professional level of the medical school graduates from the first Palestinian medical school, but nowadays, we showed the whole world that we are not below, but even better than many graduates from well known medical schools.

I returned for 3 years to Al-Quds medical school, but this time as a teaching staff (assistant professor) where I taught pharmacology and physiology to the medical and dentistry schools. I really enjoyed this period, learned new skills, and loved the contact with the students and the exchange with my colleagues (who were previously my mentors, and for whom I will always hold a huge respect).

Finally, I got the chance to continue my research in a good research institution in Lausanne University Hospital (CHUV) in Switzerland. I am a part of the team as a postdoctoral fellow for 3 years now and I am involved in two huge national projects: one in the domain of organ transplantation and the other in the domain of psychiatry, studying in both projects the genetic risk factors leading to the development of obesity, diabetes and other metabolic abnormalities in these two at risk populations. Once again, an amazing experience; learning new things with each passing day and developing my research skills, hoping one day to have my own research laboratory, and maybe having Al-Quds medical graduates as PhD students in my laboratory.

Lina Quteineh, MD, Medical School '2003